Leon Research — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Leon Research is an established, privately-held European Contract Research Organization (CRO) specializing in clinical trial management and regulatory consulting. Operating for nearly two decades, it has built a strong regional footprint in Southern Europe, supported by an ISO 9001:2015 certified quality management system. The company serves a diverse range of sponsors across multiple therapeutic areas and product types, positioning itself as a full-service outsourcing partner for the pharmaceutical and medical technology industries. Its business model is entirely service-based, generating revenue through contracted research and consulting projects.

OncologyOphthalmologyCardiologyEndocrinologyTraumatologyRare DiseasesNeurologyPneumologyHematology

Technology Platform

ISO 9001:2015 certified Quality Management System and integrated service delivery model for clinical trials and regulatory consulting, operating under ICH-GCP, ISO 14155, and EU GDPR standards.

Opportunities

Growth in European clinical trials outsourcing and complex regulatory environment favors regional CROs with local expertise.

Expansion of clinical research into medical devices, diagnostics, and nutraceuticals aligns with the company's broad service offerings.

Risk Factors

High competition from large global CROs and niche players.

Dependence on sponsor R&D spending and economic conditions.

Operational risks related to regulatory compliance and project execution in a complex EU landscape.

Competitive Landscape

Operates in a highly competitive CRO market against large multinational firms (e.g., IQVIA, ICON) and smaller regional players. Differentiates through deep regional expertise in Spain, Italy, and Portugal, flexibility, and a broad service scope covering drugs, devices, and supplements.

More companies in Spain →